The vast majority of individuals with familial hypercholesterolemia have autosomal dominant mutations of one of three genes: the LDL receptor (LDLR), apolipoprotein B (APOB) and proprotein convertase subtilisin/Kexin type 9 (PCSK) [9,10]. The gene discussed is LDLR; the disease is familial hypercholesterolemia.